-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WR1ogVQB4VADqu9R1S4yrIHp6bB6OzLkrLdBt52HFZwyOF1NOFkRg9gP+f9QaTDw jS+nkPxzKAgQCab/lNeVCQ== 0000875320-10-000001.txt : 20100119 0000875320-10-000001.hdr.sgml : 20100118 20100119133327 ACCESSION NUMBER: 0000875320-10-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100115 FILED AS OF DATE: 20100119 DATE AS OF CHANGE: 20100119 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6165776000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MUELLER PETER CENTRAL INDEX KEY: 0001256126 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 10532763 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2010-01-15 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001256126 MUELLER PETER C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET CAMBRIDGE MA 02139 0 1 0 0 EVP Global R&D, CSO Common Stock 2010-01-15 4 M 0 1600 10.41 A 118474 D Common Stock 2010-01-15 4 S 0 1300 40.09 D 117174 D Common Stock 2010-01-15 4 S 0 300 41.34 D 116874 D Common Stock 3882 I 401(k) Stock Option 10.41 2010-01-15 4 M 0 1600 0 D 2015-02-02 Common Stock 1600 32800 D Transaction made pursuant to Dr. Mueller's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $40.09 (range $39.83 to $40.37). Open market sales reported on this line occurred at a weighted average price of $41.34 (range $40.94 to $41.74). Dr. Mueller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Fully vested. Kenneth S. Boger, Attorney-In-Fact 2010-01-19 -----END PRIVACY-ENHANCED MESSAGE-----